For the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal, metastatic cancer, according to a clinical study published in Breast Cancer Research in October.
The researchers found that when cells from a breast cancer patient’s original tumor metastasized into the patient’s bone marrow with none, or only a small amount, of the protein NR2F1, the patients all soon died. However, patients who had a high concentration of NR2F1 in the cancer cells in their bone marrow did not frequently develop this type of metastatic cancer, and lived longer. The presence of a high concentration of NR2F1 induced dormancy in the cancer cells, essentially deactivating them, so this research shows that survival in these patients is due to the dormancy of the disseminated cancer.
These findings suggest that the absence of this protein in cancer cells that have spread to a patient’s bone marrow can reliably signal that the patient will relapse soon and that additional treatment is needed, while if the protein is present, the cancer cells are dormant and the patient can be monitored rather than undergo unnecessary treatment. This research is particularly important because the most common breast type of breast cancer, when it metastasizes, almost always goes to the bone.
The research is especially important in the United States because bone marrow tests, called aspirates, are not used to monitor patients there. The study was a collaboration with physicians and scientists in Oslo, Norway, where bone marrow aspirates are used to monitor patients. The laboratory of Bjorn Naume from University Hospital of Oslo collaborated with the Aguirre-Ghiso and Sosa labs at the Icahn School of Medicine at Mount Sinai and conducted the analysis of the patients’ samples from their clinical trials, thus contributing significantly to this research.
Using this research, physicians could monitor their patients with bone marrow aspirates. Tests for the protein could also help clinicians identify patients who may benefit from recently identified drugs that were shown to target cancer cells and render or keep them dormant. Studies have already shown that androgen deprivation treatment, an anti-hormone therapy used in prostate cancer, has been linked to increasing levels of the NR2F1 protein. Mount Sinai, through a trial funded by the V Foundation for Cancer Research and The Tisch Cancer Institute at the Icahn School of Medicine, has already begun recruiting prostate cancer patients for a test of the ability of two drugs to induce dormancy through NR2F1 upregulation. “This research shows that the survival advantage in these patients is due to high levels of this protein. Tests using this protein marker could further improve curative treatment of breast cancer, sparing patients from unnecessary treatments. Identifying patients with disseminated disease that is not yet symptomatic and characterizing it for potential dormancy or metastatic recurrence is a game changer,” said lead researcher Julio Aguirre-Ghiso, PhD, Director of Solid Tumor and Metastasis Research, Director of Head and Neck Cancer Basic Research, and Professor of Oncological Sciences, Otolaryngology, and Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute at the Icahn School of Medicine. “Improved techniques to assess the population of patients with residual disease and their dormant or reactivating state will be key to identifying the risk of future metastasis despite undergoing standard treatment. This opens the way for testing new treatments that prevent metastasis by inducing dormancy or eradicating the dormant disseminated cancer cells that have not yet initiated metastatic growth.”
The Latest on: Breast cancer
via Google News
The Latest on: Breast cancer
- Can turmeric help in breast cancer?on November 27, 2020 at 9:02 pm
I was recently diagnosed with breast cancer and I will have surgery, followed by chemotherapy. A friend told me that turmeric has anti-cancer properties. I have taken turmeric supplements in the past ...
- 'Turncoat' macrophages in the tumor 'micro-environment' underlie breast cancer progressionon November 27, 2020 at 11:31 am
New research that is examining the "tumor microenvironment" reveals not only how macrophages can become extraordinary turncoats but also how they can actively support tumor growth and metastatic ...
- Frozen Eggs Help Breast Cancer Survivors Conceiveon November 27, 2020 at 7:18 am
Freezing their eggs or ovarian tissue before breast cancer treatment increases survivors' chances of having children after recovery, a new study finds. Nearly 10% of breast cancer cases occur in women ...
- Mum-of-four, 35, diagnosed with aggressive breast cancer reveals the strange warning sign she had that EVERY woman should know abouton November 27, 2020 at 6:47 am
Four days after her 33rd birthday, Victorian primary school teacher Jen Grieger received news that made her wonder whether she would live to see her four young children grow up.
- Covid is masking the symptoms of deadliest cancer in UK – the 10 signs you must never ignoreon November 27, 2020 at 5:10 am
COVID-19 is masking the symptoms of the deadliest cancer in UK, experts say. Lung cancer, which kills more than 35,300 Brits a year, has very similar characteristics to the coronavirus. The most ...
- 'Molecular clock' blood test could track spread of breast canceron November 27, 2020 at 3:58 am
A blood test to watch breast cancer's 'molecular clock' could help track the growth of multiple tumours around the body and monitor how they are responding to treatment, new research suggests.
- ‘Molecular clock’ blood test could help identify actively growing tumors in metastatic breast canceron November 26, 2020 at 9:39 pm
A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumors around the body and monitor how they are responding to treatment, new research suggests.
- New blood test could monitor how breast cancer spreads in multiple organson November 26, 2020 at 5:47 pm
A new blood test is able to monitor the spread of breast cancer in a number of organs and keep tabs on whether treatment is working. The test, which has been created by scientists in the UK, can ...
- In sickness and in health: How my high-risk diagnosis for a breast cancer gene revived my marriageon November 25, 2020 at 6:41 pm
After surviving a life-altering diagnosis and multiple prophylactic surgeries, Lilith Costa realized her next mission was learning how to connect with her husband again.
via Bing News